Greenland Mines Ltd. (GRML) focuses on developing innovative therapeutic solutions to combat neurodegenerative diseases. The company's primary treatment modalities involve cutting-edge cell and gene therapies. Joseph Sinkule founded this enterprise on August 2, 2004, and its corporate operations are based in Omaha, Nebraska.
Greenland Mines Provides Corporate and Operational Update; Announces 1-for-50 Reverse Stock Split
Greenland Mines announced a 1-for-50 reverse stock split effective August 24, 2026, aimed at regaining compliance with Nasdaq's minimum bid price requirement and reducing shares outstanding from approximately 158.9 million to 3.2 million.
Operationally, the company reported progress at its Skaergaard project where an updated S-K 1300 Technical Report showed Indicated PdEq grade increasing 36% and contained ounces rising 31%, now containing approximately 7.6 million ounces of palladium and 3.2 million ounces of gold.
At the Sarfartoq project, subject to closing of the acquisition, Greenland Mines plans to launch geological mapping in September and has engaged WSP Denmark for environmental baseline work while securing a First Right of Refusal on the Helguvik industrial complex in Iceland.